63例肝转移瘤介入治疗临床疗效分析  

Interventional Chemoembolization for Metastatic Liver Cancer:The Clinical Analysis of 63 Cases

作　　者：谢印法[1] 张鑫[1] 李玲[1] 张慧芳[1] 薛洪范[1] 李青[1] 

机构地区：[1]山东省肿瘤防治研究院外一科,济南市250117

出　　处：《肿瘤防治杂志》2000年第3期277-278,共2页China Journal of Cancer Prevention and Treatment

摘　　要：目的 :探讨肝转移治疗 (TAITAE)和预后间的关系。方法 :回顾分析山东省肿瘤防治研究院1995年 5月～ 1997年 5月收治的 63例肝转移瘤介入治疗患者。结果 :总有效率 (CR +PR) 87.3%。 6个月、1年、2年生存率分别为 92 .0 %、71.4 %、33.3%。结论 :介入治疗是转移性肝癌的一种有效方法 ,具有疗效高、副作用小。Objective:To study the relationship bewtween the interventional chemoembolization and the survival rate of metastatic liver cancer.Methods:From May 1995 to May 1997,63 patients with metastatic liver cancer were treated by interventional chemoembolization.Result:The whole effective rate was 87.3%(CR 12 and PR 43).The six month,one year,two year survival rate were 92.0%,71.4%,33.3%,respeitively.Conclusion:The interventional chemoembolization was an effective treatment to metastatic liver cancer.It has higher theraputic effect and longer remission time and little side effect.

关 键 词：肝转移瘤 治疗性化学栓塞 预后 

分 类 号：R735.7[医药卫生—肿瘤]